The DOI matches its Crossref record; 49 of the 52 references it cites were found in a registry or an index, and 2 are not checked yet.
Cross-reactive memory T cells and herd immunity to SARS-CoV-2
Open accessAbstract
Immunity is a multifaceted phenomenon. For T cell-mediated memory responses to SARS-CoV-2, it is relevant to consider their impact both on COVID-19 disease severity and on viral spread in a population. Here, we reflect on the immunological and epidemiological aspects and implications of pre-existing cross-reactive immune memory to SARS-CoV-2, which largely originates from previous exposure to circulating common cold coronaviruses. We propose four immunological scenarios for the impact of cross-reactive CD4+ memory T cells on COVID-19 severity and viral transmission. For each scenario, we discuss its implications for the dynamics of herd immunity and on projections of the global impact of SARS-CoV-2 on the human population, and assess its plausibility. In sum, we argue that key potential impacts of cross-reactive T cell memory are already incorporated into epidemiological models based on data of transmission dynamics, particularly with regard to their implications for herd immunity. The implications of immunological processes on other aspects of SARS-CoV-2 epidemiology are worthy of future study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“lymphocytes from 20% to 50% of unexposed donors display significant reactivity to SARS-CoV-2 Ag peptide pools (Figure 6).”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [111]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This cross-reactivity largely originates from previous exposure to circulating common cold coronaviruses [110-116].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [111]
In the citing paper
“It is possible that cross-protection via adaptive immune responses against endemic coronaviruses might be in part responsible for mild disease courses in younger individuals (Lipsitch et al., 2020).”
From COVID-19 and the human innate immune system (2021) · cites this paper as Lipsitch et al., 2020
In the citing paper
“at least some individuals are low or negative to commercial IgG assays, while retaining detectable SARS-CoV-2 CD4+ T cells. Current estimates are these individuals represent 1%–10% of PCR-confirmed SARS-CoV-2 infections (Gudbjartsson et al., 2020; Lipsitch et al., 2020; Nelde et al., 2021; Schwarzkopf et al., 2021; Sekine et al., 2020).”
From Adaptive immunity to SARS-CoV-2 and COVID-19 (2021) · cites this paper as Lipsitch et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Héry-Arnaud, G., Berre, R. L., Loaëc, N., Oumata, N., Galons, H., Nowak, E., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000444256 · Cited by 5,008
Temporal dynamics in viral shedding and transmissibility of COVID-19
He, X., Lau, E. H. Y., Wu, P., Deng, X., Wang, J., Hao, X., Lau, Y. C., Wong, J. Y., Guan, Y., Tan, X., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0869-5 · Cited by 4,300
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595
Self-citationClinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Long, Q.-X., Tang, X.-J., Shi, Q.-L., Li, Q., Deng, H.-J., Yuan, J., Hu, J.-L., Xu, W., Zhang, Y., Lv, F.-J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0965-6 · Cited by 2,686
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
Kissler, S. M., Tedijanto, C., Goldstein, E., Grad, Y. H., & Lipsitch, M. (2020) · Science · doi:10.1126/science.abb5793 · Cited by 2,611
Self-citationSuperspreading and the effect of individual variation on disease emergence
Lloyd-Smith, J. O., Schreiber, S. J., Kopp, P. E., & Getz, W. M. (2005) · Nature · doi:10.1038/nature04153 · Cited by 2,514
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Le Bert, N., Tan, A. T., Kunasegaran, K., Tham, C. Y. L., Hafezi, M., Chia, A., Chng, M. H. Y., Lin, M., Tan, N., Linster, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2550-z · Cited by 1,887
Rydyznski Moderbacher, C., Ramirez, S. I., Dan, J. M., Grifoni, A., Hastie, K. M., Weiskopf, D., Belanger, S., Abbott, R. K., Kim, C., Choi, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.038 · Cited by 1,790
Self-citationRobust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.017 · Cited by 1,788
A serological assay to detect SARS-CoV-2 seroconversion in humans
Amanat, F., Stadlbauer, D., Strohmeier, S., Nguyen, T. H. O., Chromikova, V., McMahon, M., Jiang, K., Arunkumar, G. A., Jurczyszak, D., Polanco, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0913-5 · Cited by 1,769
Cited by
Sorted by citations
Items 201–259 of 259
Gobeil, P., Pillet, S., Boulay, I., Charland, N., Lorin, A., Cheng, M. P., Vinh, D. C., Boutet, P., der Most, R. G. V., Roman, F. P., et al. (2021) · medRxiv · doi:10.1101/2021.08.04.21261507 · Cited by 3
Lung-resident SARS-CoV-2 peptide-specific immune responses in perfused 3D human lung explant models
Goliwas, K. F., Wood, A. M., Simmons, C. S., Khan, R., Khan, S. A., Wang, Y., Ramachandran, R., Berry, J. L., Athar, M., Mobley, J. A., et al. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1587080 · Cited by 2
Gobena, D., Gudina, E. K., Tilahun, T., & Mekonnen, Z. (2026) · Scientific Reports · doi:10.1038/s41598-026-36177-y · Cited by 2
Tongsengkee, N., Surasombatpattana, S., Tanomkiat, W., Siripaitoon, P., Kositpantawong, N., Kanchanasuwan, S., Navasakulpong, A., Pinpathomrat, N., Dechaphunkul, A., Phongphithakchai, A., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041388 · Cited by 2
ScRNA-Seq reveals T cell immunity in COVID-19 patients and implications for immunotherapy
Yao, Z., Feng, Z., Zhang, H., & Zhang, B. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114663 · Cited by 2
Tok, Y., Kuşkucu, M. A., Sarıbal, D., Yılmaz, S. S., Nohut, O. K., Aygün, G., & Midilli, K. (2021) · Mikrobiyoloji Bulteni · doi:10.5578/mb.20219704 · Cited by 2
Rivas, M. N., Rosser, C. J., & Arditi, M. (2021) · Bladder Cancer · doi:10.3233/blc-201529 · Cited by 2
Louis, I. V.-S., Gorzalski, A., & Pandori, M. (2021) · Applications of RNA-Seq in Biology and Medicine [Working Title] · doi:10.5772/intechopen.99156 · Cited by 3
Fabricius, G., Borzi, R. A., Caminos, J., & Grigera, T. S. (2022) · Epidemiology and Infection · doi:10.1017/s0950268822000656 · Cited by 1
Shahriar, A., Mahmud, A. R., Ahmed, H. M., Rahman, N., & Khatun, M. C. (2021) · Austin Journal of Microbiology · doi:10.26420/austinjmicrobiol.2021.1028 · Cited by 2
Krishna, B. A., Lim, E. Y., Mactavous, L., NIHR BioResource Team, Lyons, P., Döffinger, R., Bradley, J. R., Smith, K. G. C., Sinclair, J. H., Matheson, N. J., et al. (2021) · SSRN Electronic Journal · doi:10.21203/rs.3.rs-989434/v1 · Cited by 2
Nazar, F. A. (2021) · Thesis Commons (OSF Preprints) · doi:10.31237/osf.io/trz5s · Cited by 2
Tissue-intrinsic γδ T cells critically regulate Tissue-Resident Memory CD8 T cellsPreprint
Muñoz‐Ruiz, M., Llorian, M., D’Antuono, R., Pavlova, A., Mavrigiannaki, A. M., McKenzie, D. R., García-Cassani, B., Iannitto, M. L., Jandke, A., Ushakov, D. S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.19.476598 · Cited by 2
West African pre-pandemic cross-reactive antibody and cellular responses against SARS-CoV-2Preprint
Herrera, B. B., Chaplin, B., Mboup, S., Abdullahi, A., He, M., Fisher, S. M., Akanmu, S. A., Chang, C. A., Hamel, D. J., Gupta, R. K., et al. (2024) · medRxiv · doi:10.1101/2024.05.21.24307417 · Cited by 2
The role of T cell immunity in COVID-19
Stervbo, U., & Babel, N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18566-3.00021-9 · Cited by 1
Guo, Y., Guo, P., Tian, J., Tuluhongtayi, Y., Song, R., Gao, G. F., Zhao, X., & Liu, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1731340 · Cited by 1
Cellular Immune Response Induced by mRNA Vaccines Against SARS‐CoV‐2
Tovar, V., Sánchez, I. P., Rugeles, M. T., Taborda, N. A., & Hernández, J. C. P. (2026) · Immunity Inflammation and Disease · doi:10.1002/iid3.70375 · Cited by 1
Updated profiling of COVID-19 vaccine adverse events using VAERS case reports
He, A., Hur, K., Li, X., Zheng, J., Hur, J., & He, Y. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1741967 · Cited by 1
Kohler, P. P., Jónsdóttir, H. R., Risch, L., Vernazza, P., Ackermann‐Gäumann, R., & Kahlert, C. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-03685-y · Cited by 1
Molina, L. D. P., Bravo‐Gallego, L. Y., Nozal, P., Serrano, Y. S., Martínez‐Feito, A., Reche-Yebra, K., González‐Torbay, A., de la Cámara, R. C., Gianelli, C., Cámara, C., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1136308 · Cited by 1
Lazăr, V., & Ancuța, P. (2021) · Romanian Archives of Microbiology and Immunology · doi:10.54044/rami.2021.01.07 · Cited by 1
Predicting of poor outcomes in COVID-19 patients: Experience from an Argentinean hospital
Castro, M. G., Sadonio, M. J., Landaburo, A. A. C., Cuevas, G., Cogliano, F., & Galluccio, F. R. (2021) · Iberoamerican Journal of Medicine · doi:10.53986/ibjm.2021.0050 · Cited by 1
Nugroho, R. A., Kasmiyati, S., Kristiani, E. B. E., Meitiniarti, V. I., & Krave, A. (2021) · Engagement: Jurnal Pengabdian Kepada Masyarakat · doi:10.29062/engagement.v5i2.788
López‐Goñi, I. (2020) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2020-0105 · Cited by 1
Even vaccinated against COVID-19, we must continue to wear a mask
Zahar, J., & Allaouchiche, B. (2021) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2021.100849 · Cited by 1
Pre-existing and post-COVID-19 immune responses to SARS-CoV-2 in cancer patientsPreprint
Bilich, T., Roerden, M., Maringer, Y., Nelde, A., Heitmann, J. S., Dubbelaar, M. L., Peter, A., Hörber, S., Bauer, J., Rieth, J., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-237290/v1 · Cited by 2
Is it of any positive being COVID-19 positive?: Cross-protection hypothesisPreprint
Alser, M. (2021) · doi:10.32388/zszh3f
Is it of any positive being COVID-19 positive?: Cross-protection hypothesisPreprint
Alser, M. (2021) · doi:10.32388/zszh3f.2
N’Guessan, A., Kailasam, S., Mostefai, F., Poujol, R., Grenier, J., Contini, P., Palma, R. D., Haber, C., Stadler, V., Bourque, G., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.01.494373 · Cited by 1
ScRNA-Seq Reveals T Cell Immunity in COVID-19 Patients and Implications for ImmunotherapyPreprint
Zhang, B., Feng, Z., Jiao, A., & Zhang, H. (2024) · doi:10.22541/au.170663818.80204228/v1 · Cited by 1
López‐Goñi, I. (2020) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2020-0100
Case fatalities due to COVID-19: Why there is a difference between the East and West?
Yaqinuddin, A., Ambia, A. R., & Elgazzar, T. A. (2021) · AIMS Allergy and Immunology · doi:10.3934/allergy.2021005
Sars-Cov-2 virus and vaccination; biological and statistical framework
Arslan, F., & Ankarali, H. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1965884
Influenza Related Mortality in Populations That Fail to Reach Herd ImmunityPreprint
Premenko-Lanier, M., Parkman, L., & Quesada, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1236624/v1
The effectiveness of the immune responses to SARS-CoV-2
Salih, B. A. (2022) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000306
Is it of any positive being COVID-19 positive?: cross-protection hypothesisPreprint
Alser, M. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/9dtcw
The Rationale Behind the Effectiveness of COVID-19 Vaccines and Associated Immunological Mechanisms
Khatib, S. E. (2022) · Turkish Journal of Immunology · doi:10.4274/tji.galenos.2022.55264
Data from Preexisting and Post–COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
Bilich, T., Roerden, M., Maringer, Y., Nelde, A., Heitmann, J. S., Dubbelaar, M. L., Peter, A., Hörber, S., Bauer, J., Rieth, J., et al. (2023) · doi:10.1158/2159-8290.c.6549020.v1
Arons, E., Henry, K. N., Haas, C. J., Gould, M., Tsintolas, J., Mauter, J. T., Zhou, H., Burbelo, P. D., Cohen, J. I., & Kreitman, R. J. (2023) · Journal of Medical Virology · doi:10.1002/jmv.29179
An Infectious Disease Model with Asymptomatic Transmission and Waning Immunity
Rong, S. Y., Li, A. X., Gao, S., & Wang, C. (2024) · SIAM Undergraduate Research Online · doi:10.1137/23s1606411
Computational Modeling of Viral Infection and Immune Response in COVID-19 Patients
Lefraich, H. (2024) · Springer eBooks · doi:10.1007/978-3-031-59072-6_7
SARS-CoV-2 Vaccination in Primary Humoral Immunodeficiency: Experience from a German Lung Clinic
Rosendahl, S., Trudzinski, F. C., Polke, M., Herth, F. J. F., Kreuter, M., & Giese, T. (2024) · Respiration · doi:10.1159/000543146
Scaling, Power-Law First Return Times, and Non-Ergodicity
Lambert, D. R. (2022) · University of North Texas Digital Library (University of North Texas) · doi:10.12794/metadc1987323
Porta, M. S., Pumarega, J. A., Aguilar, R., Prieto‐Merino, D., Campi, L., Rius, C., Villar-García, J., Vidal, M., Jiménez, A., Peña‐Fernández, A., et al. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1548456 · Cited by 1
Валерьевич, С. Т., Kopat, V. V., Даниленко, Е. Д., Churin, A. A., Milichkina, A. M., Ramsay, E. S., Dukhovlinov, I. V., Simbirtsev, A. S., & Тотолян, А. А. (2025) · Viruses · doi:10.3390/v17091186
Perevaryukha, A. Y. (2025) · Technical Physics Letters · doi:10.1134/s1063785025700294
The great balancing debate: a history of observing and cultivating herd immunity, 1920–2020
Robertson, D. (2025) · Medical History · doi:10.1017/mdh.2025.10040
Perevaryukha, A. Y. (2025) · Technical Physics · doi:10.1134/s1063784225700434
Tongsengkee, N., Pinpathomrat, N., Siripaitoon, P., Kositpantawong, N., Kanchanasuwan, S., Chittrakarn, S., & Chusri, S. (2026) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000001577
Serial vaccination expands and refines human CD4 + T cell memoryPreprint
Lai, Y., Su, X., Awad, S., Ansari, A. H., Jang, J., Saber, A. O., Chen, H.-W., Jung, H., Sarkar, A., Drapeau, E. M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.11.716570
Modeling Unstable Critical States and Activity Waves in Social Network Communications
Perevaryukha, A. Y. (2025) · Journal of Communications Technology and Electronics · doi:10.1134/s1064226926600280
Perevaryukha, A. Y. (2026) · Technical Physics · doi:10.1134/s1063784226700143
Owusu‐Boaitey, N., Meyer, M. J., Herrera, D., Böttcher, L., Lukz, M., Cook, S., Stoto, . A., & Kraemer, J. D. (2026) · medRxiv · doi:10.64898/2026.06.09.26355264
Marlin, R., Centlivre, M., Bossevot, L., Gallouët, A.-S., Alexandre, M., Planas, D., Cavarelli, M., Staropoli, I., Gros, W., Surénaud, M., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106361 · Cited by 1
Metadata
- Authors
- Lipsitch, M., Grad, Y. H., Sette, A., & Crotty, S.
- Affiliations
- Harvard University (US)
- La Jolla Institute for Immunology (US)
- Corresponding author
- Lipsitch, Marc
- Grad, Yonatan H.
- Sette, Alessandro
- Crotty, Shane
- Venue
- Nature Reviews Immunology
- Published
- 2020-10-06
- Volume
- 20
- Issue
- 11
- Pages
- 709-713
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC7537578
- OpenAlex
- W3091791643
- Cited by
- 260
- References
- 48
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 12 · 2023: 29 · 2022: 59 · 2021: 129 · 2020: 9
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (75N9301900065)
- National Institute of Allergy and Infectious Diseases (U19 AI42742, 75N9301900065, AI42742, U19AI142742)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Keywords
- SARS-CoV-2, cross-reactive T cells, memory CD4+ T cells, herd immunity threshold, COVID-19 severity, common cold coronaviruses, pre-existing immunity, virus transmission, epidemic modeling, COVID-19 pandemic
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, COVID-19 Vaccines, Antibodies, Viral, Coronaviridae, Coronaviridae Infections, Cross Reactions, Humans, Immunologic Memory, Pneumonia, Viral, Rhinovirus, Viral Vaccines, CD4-Positive T-Lymphocytes, Coronavirus Infections, Immunity, Herd, Adaptive Immunity, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
